The reason to trust a page about a medication is that the people who wrote it have nothing to sell you. That is the entire premise of GLP Notes.
No manufacturer money
GLP Notes is not affiliated with, endorsed by, or sponsored by Novo Nordisk, Eli Lilly, or any manufacturer. We accept no manufacturer funding, no sponsored placements, and no editorial input from any commercial party. Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Saxenda, and Trulicity are trademarks of their respective owners; we use those names only to identify the medications we describe.
No products, no affiliates
We sell nothing — no supplements, no programs, no telehealth referrals — and we run no affiliate links. When we mention a brand, a compounding pharmacy, or a telehealth service, it is to inform you, never to earn a commission. We do not publish a "best GLP-1 vendor" page, because there is no honest version of one on a site that wants to stay neutral.
Why neutrality is the product
Patients are surrounded by two kinds of GLP-1 information: manufacturer pages that are accurate but promotional, and affiliate-driven blogs that are friendly but conflicted. The empty seat is the independent third party that simply tells you what the evidence shows. Neutrality is not a marketing line for us; it is the only thing that makes our pages worth reading.
How we are funded
GLP Notes is editorially independent and intends to stay that way. If we ever introduce a funding model, it will be disclosed here plainly, and it will never include manufacturer money or anything that lets a seller influence our content.
Every clinical claim above is cited inline to a primary source. See how we review and our sourcing & fact-check standards.